HomeCompareSTRN vs JNJ

STRN vs JNJ: Dividend Comparison 2026

STRN yields 0.20% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $66.00 in total portfolio value· pulled ahead in Year 10
10 years
STRN
STRN
● Live price
0.20%
Share price
$19.84
Annual div
$0.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$20.75
Full STRN calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — STRN vs JNJ

📍 JNJ pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSTRNJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, STRN + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
STRN pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

STRN
Annual income on $10K today (after 15% tax)
$17.40/yr
After 10yr DRIP, annual income (after tax)
$17.64/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $685.98/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of STRN + JNJ for your $10,000?

STRN: 50%JNJ: 50%
100% JNJ50/50100% STRN
Portfolio after 10yr
$20.0K
Annual income
$424.26/yr
Blended yield
2.12%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

STRN
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

STRN buys
0
JNJ buys
0
No recent congressional trades found for STRN or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSTRNJNJ
Forward yield0.20%3.36%
Annual dividend / share$0.04$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$20.0K$20.0K
Annual income after 10y$20.75$827.78
Total dividends collected$206.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: STRN vs JNJ ($10,000, DRIP)

YearSTRN PortfolioSTRN Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,720$20.47$10,676$355.77+$44.00STRN
2$11,491$20.51$11,407$389.39+$84.00STRN
3$12,316$20.55$12,198$426.53+$118.00STRN
4$13,199$20.58$13,056$467.62+$143.00STRN
5$14,144$20.62$13,987$513.12+$157.00STRN
6$15,154$20.65$14,998$563.56+$156.00STRN
7$16,236$20.67$16,098$619.52+$138.00STRN
8$17,393$20.70$17,295$681.69+$98.00STRN
9$18,631$20.73$18,599$750.82+$32.00STRN
10← crossover$19,956$20.75$20,022$827.78$66.00JNJ

STRN vs JNJ: Complete Analysis 2026

STRNStock

STRN is actively managed with exposure to large-cap companies listed on US exchanges. The investment universe begins with the 800 largest US equities, then narrowing it to the top 50% based on stock price momentum and intrinsic value analysis. Using proprietary quantitative ranking, the top 25% are further filtered by historical price momentum and performance trends. The final portfolio comprises 25 stocks weighted by market-cap, with individual positions capped at 8% and a minimum 1% position size. Sector exposure is limited to 30%. The fund utilizes third-party tools, public data, and industry trends to optimize risk-return characteristics in the aim of providing returns that may exceed those of the S&P 500 Index. Positions are reassessed monthly.

Full STRN Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this STRN vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

STRN vs SCHDSTRN vs JEPISTRN vs OSTRN vs KOSTRN vs MAINSTRN vs ABBVSTRN vs MRKSTRN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.